FDA Drug Application (203253) for SPIRONOLACTONE by JUBILANT GENERICS

Back to FDA Applications sponsored by JUBILANT GENERICS

Application Number203253
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSPIRONOLACTONE
Active IngredientSPIRONOLACTONE

Active IngredientCount
List of drugs with Active Ingredient SPIRONOLACTONE5


Back to FDA Applications sponsored by JUBILANT GENERICS